SYNEOS HEALTH NORWAY AS
Operating
Drive forskning og utvikling av farmasøytiske produkter og
bruksområder, samt kunne bringe denne medisin ut til markedet og alt
hva dermed er forbundet.
Organization
- Chairman of the board
- MT
- Years since formation
- 6 years
- since Jun 13, 2020
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 11
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 14,176,584
- NOK
- Annual total result 2025
- 689,900
- NOK
- Total equity 2025
- 2,581,005
- NOK
Last update: Nov 12, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
MT | Chairman | - |
| Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Last update: Oct 6, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 30,000 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 14,176,584 | 13,762,273 | 14,029,058 | 13,265,878 | 7,077,046 |
Annual Total Result | 689,900 | 543,614 | 103,621 | 834,033 | 283,811 |
Total assets | 4,815,350 | 3,829,875 | 3,402,207 | 4,436,457 | 1,972,001 |
Total liabilities | 2,234,345 | 1,938,770 | 2,054,716 | 3,192,587 | 1,562,165 |
Total equity | 2,581,005 | 1,891,105 | 1,347,491 | 1,243,870 | 409,837 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 14,176,584 | 13,762,273 | 14,029,058 | 13,265,878 | 7,077,046 |
Total operating costs | 13,337,645 | 13,107,319 | 13,978,385 | 12,203,826 | 6,705,232 |
Operating result | 838,939 | 654,954 | 50,673 | 1,062,052 | 371,814 |
Financial income/costs | 46,724 | 43,581 | 83,488 | 7,025 | -7,756 |
Profit before tax | 885,663 | 698,536 | 134,161 | 1,069,077 | 364,058 |
Total tax & extraordinary income/cost | 195,763 | 154,922 | 30,540 | 235,044 | 80,247 |
Annual Total Result | 689,900 | 543,614 | 103,621 | 834,033 | 283,811 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 45,912 | 39,345 | 58,377 | 62,920 | 47,191 |
Total current assets | 4,769,438 | 3,790,530 | 3,343,830 | 4,373,537 | 1,924,811 |
Total assets | 4,815,350 | 3,829,875 | 3,402,207 | 4,436,457 | 1,972,001 |
Short term debt | 2,234,345 | 1,938,770 | 2,054,716 | 3,191,737 | 1,562,165 |
Long term debt | 0 | 0 | 0 | 850 | 0 |
Total liabilities | 2,234,345 | 1,938,770 | 2,054,716 | 3,192,587 | 1,562,165 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | 2,551,005 | 1,861,105 | 1,317,491 | 1,213,870 | 379,837 |
Total equity | 2,581,005 | 1,891,105 | 1,347,491 | 1,243,870 | 409,837 |
Total equity and liabilities | 4,815,350 | 3,829,875 | 3,402,207 | 4,436,457 | 1,972,001 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification